Partners Group Holding’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-8,443
Closed -$214K 94
2022
Q3
$214K Hold
8,443
0.02% 96
2022
Q2
$280K Sell
8,443
-2,975
-26% -$126K 0.02% 103
2022
Q1
$824K Buy
11,418
+6,674
+141% +$481K 0.04% 47
2021
Q4
$436K Hold
4,744
0.02% 97
2021
Q3
$602K Buy
+4,744
New +$691K 0.04% 66

Other funds holding TDOC

Partners Group Holding's TDOC Position: Q4 2022 in Review

Partners Group Holding sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 8,443 shares — an estimated $214K sold.

Partners Group Holding first reported a position in TDOC in Q3 2021 and held it in 5 quarters. The position peaked at $824K in Q1 2022. 444 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Partners Group Holding reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Partners Group Holding sold 8,443 Teladoc Health shares in Q4 2022, an estimated $214K.
  • Partners Group Holding first reported a position in Teladoc Health in Q3 2021 and held it in 5 quarters.
  • Partners Group Holding's Teladoc Health position peaked at $824K in Q1 2022.
  • 444 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Partners Group Holding's 13F filing for Q4 2022, filed 14 Feb 2023.